Patent · US Expired

Pharmaceutical composition and method for the treatment of hydropic conditions

US4031213A · kind A · utility

0Cited by

1References

12Claims

0Family size

Assignee

Boehringer Mannheim GmbH · DE

Inventors

Rolf Kuhn · Ingelheim am Rhein, DE
Klaus Hardebeck
Helmut Heinemann · Kelkheim, DE

Key dates

Filing date	Apr 16, 1975
Grant date	Jun 21, 1977
Priority date	—
Expiry date	Apr 16, 1995

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/565
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions comprising PA1 A. at least one member of 5-(4-chloro-5-sulfamoyl-2-thenylaminophenyl)-tetrazole and the pharmacologically compatible salts thereof, PA1 B. 3-(3-oxo-7.alpha.-acetylthio-17.beta.-hydroxy-4-androsten-17.alpha.-yl)-pr opionic acid-.gamma.-lactone, and PA1 C. a pharmaceutical diluent or carrier Possess outstanding activity for treating hydropic conditions and prevent undesirable increased excretion of potassium without at the same time impairing the desired excretion of water and sodium.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.